Dr. Uri Geiger | Source | Founder & Managing Partner at Accelmed
Dr. Uri Geiger
Uri Geiger brings extensive entrepreneurial, management and investment know-how, having created and built many successful medical device enterprises. Prior to founding Accelmed, Dr. Geiger founded served as CEO of Exalenz Bioscience Ltd., developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders which Dr. Geiger took public in 2007 and later sold to Meridian. Dr. Geiger was formerly an adjunct professor at the Recanati Business School at Tel Aviv University, where he lectured on private equity and venture capital.
-
We have built our business on the belief that increasing the conversion of healthcare and technology materially improves individuals’ lives, addresses society’s unmet healthcare needs, and ultimately drives down the cost of healthcare. The strong support Fund II received from a diverse group of institutional investors and prominent family offices is a testament to their confidence in our strategy and ability to identify companies at the nexus of healthcare and innovation and partner with them to drive significant value.
-
Accelmed Partners Raises $400 Million to Invest in Commercial Stage HealthTech
Accelmed fund II
Article
-
Accelmed
Founder & Managing Partner